Division of Hematology/Oncology

The Penn Difference

Why Referring Physicians Choose Penn Medicine

The unique capabilities of Penn's Division of Hematology/Oncology make it a national referral center. Referring physicians trust the physicians, nurses and the entire health care team with their patients because:

  • Penn's hematologists/oncologists are committed to all patients, including patients with complex or high-risk conditions that cannot be treated at other hospitals.
  • More bone marrow and stem cell transplants are performed at Penn than any other program in the region.
  • Penn's hematologists/oncologists are actively researching new treatments for patients including vaccines, immunotherapy, targeted therapies and other innovative new treatments.
  • Penn Hematology/Oncology is a part of Penn's Abramson Cancer Center, designated a comprehensive cancer center by the National Cancer Institute and rated "exceptional" in its most recent peer review.
  • Robust research programs allow Penn researchers and clinicians to develop and bring breakthrough medical advances out of the lab and turn them into cutting-edge treatments for patients.
  • Penn Medicine offers unique risk-reduction and treatment programs for people who are genetically predisposed to cancer and blood disorders.

Penn Hematology/Oncology fosters relationships with referring physicians seamlessly through Penn PhysicianLink™, an exclusive program that connects referring physicians with Penn Medicine through:

  • Dedicated, physician-only telephone lines that provide rapid access to Penn Medicine physicians for consults, referrals and transfers.
  • Single-call consultations and transfer process to assist physicians in transferring patients from another health care facility to Penn Medicine.

Learn more about Penn PhysicianLink™